» Articles » PMID: 18305573

Mite and Cockroach Allergens Activate Protease-activated Receptor 2 and Delay Epidermal Permeability Barrier Recovery

Overview
Publisher Elsevier
Specialty Dermatology
Date 2008 Feb 29
PMID 18305573
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Protease-activated receptor-2 (PAR-2) is known to be involved in epidermal permeability barrier function homeostasis. PAR-2 activation occurs after barrier disruption and further activation of PAR-2 by activating peptide significantly delays barrier recovery rate. Cockroach and house dust mite allergens, both known to be associated with the development of asthma, allergic rhinitis, and atopic dermatitis, have protease activity, which can activate PAR-2. In this study, we investigated the effects of both allergens on the epidermal barrier function as well as on the epidermal calcium gradient. Both allergens, when topically applied on the barrier-disrupted site, increased protease activities in the epidermis and delayed barrier recovery and lamellar body secretion in murine skin. The topical application of PAR-2-specific antagonist or protease inhibitors normalized the barrier recovery. Cockroach allergens induced intracellular calcium oscillations in cultured human keratinocytes through PAR-2-involved pathway, which was confirmed by desensitization protocol. Abnormal calcium ion distribution after barrier disruption was also observed in allergens-applied skin. These results suggest that allergens with protease activity can influence the epidermal permeability barrier homeostasis through PAR-2 activation and consequent modulation of the calcium ions in skin.

Citing Articles

Allergens in Atopic Dermatitis.

Zhang J, Li G, Guo Q, Yang Y, Yang J, Feng X Clin Rev Allergy Immunol. 2025; 68(1):11.

PMID: 39924626 DOI: 10.1007/s12016-025-09024-7.


From the bench to the clinic: basophils and type 2 epithelial cytokines of thymic stromal lymphopoietin and IL-33.

Obata-Ninomiya K, Jayaraman T, Ziegler S Clin Transl Immunology. 2024; 13(12):e70020.

PMID: 39654685 PMC: 11626414. DOI: 10.1002/cti2.70020.


Update on protease-activated receptor 2 in inflammatory and autoimmune dermatological diseases.

Xu K, Wang L, Lin M, He G Front Immunol. 2024; 15:1449126.

PMID: 39364397 PMC: 11446762. DOI: 10.3389/fimmu.2024.1449126.


Protease-Activated Receptor 2 in inflammatory skin disease: current evidence and future perspectives.

Fan M, Fan X, Lai Y, Chen J, Peng Y, Peng Y Front Immunol. 2024; 15:1448952.

PMID: 39301020 PMC: 11410643. DOI: 10.3389/fimmu.2024.1448952.


Ceramide AD™ Restores Skin Integrity and Function following Exposure to House Dust Mite.

Bzioueche H, Tamelghaghet M, Chignon-Sicard B, Bazile N, Hauchecorne P, Barbero Calderon M Int J Mol Sci. 2023; 24(11).

PMID: 37298186 PMC: 10252232. DOI: 10.3390/ijms24119234.